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Associations between shift work and use of prescribed medications for the treatment of 
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use of prescribed medications for the treatment of hypertension, diabetes, and dyslipidemia: a prospective cohort study. 
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Objective   This study examined the associations between shift work and use of antihypertensive, lipid-lowering, 
and antidiabetic medications.
Methods   Survey data from two cohorts of Finnish men (N=11 998) and women (N=49 944) working in multiple 
occupations where shift work was used were linked to national Drug Prescription Register data, with up to 11 
years of follow-up. In each cohort, age-stratified Cox proportional hazard regression models were computed to 
examine any incident use of prescription medication for each of the three medical conditions, separately compar-
ing each of two groups of rotating shift workers (those whose schedules included night shifts, and those whose 
schedules did not include night shifts) with day workers who worked in a similar range of occupations.
Results   In the larger cohort, among participants aged 40–49 at baseline, shift work without night shifts was 
associated with increased use of type-2 diabetes medication after adjustments for sex, occupational status, marital 
status, alcohol consumption, smoking, and physical activity [hazard ratio (HR) 1.28, 95% confidence interval 
(CI) 1.01–1.62], while shift work with night shifts was associated with increased use of dyslipidemia medica-
tion after adjustments (HR 1.33, 95% CI 1.12–1.57). There were no such associations among younger and older 
shift workers. Also in the larger cohort, among those aged <50 years at baseline, both types of shift work were 
associated with increased use of hypertension medication after adjustments [up to HR 1.20 (95% CI 1.05–1.37)]. 
There were no positive associations in the smaller cohort.
Conclusions   There was mixed evidence regarding the use of medications for cardiovascular risk factors by shift 
workers. Selection effects may have affected the associations.
Key terms   cardiovascular disease; coronary heart disease; drug register; night shift; night work; rotating shift; 
shift worker.
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Shift workers are exposed to higher levels of physi-
ological stress than their day-working counterparts due, 
at least in part, to chronic exposure to circadian disrup-
tion. This may increase shift workers' susceptibility to 
cardiovascular risk factors, such as hypertension, athero-
sclerosis, and type 2 diabetes (1). However, while some 
studies have identified associations between exposure 
to shift work and such medical conditions, the overall 
picture is of a mixed set of findings.
Many studies (eg, as reviewed by 2–6) have vari-
ously suffered from being based on relatively small 
samples or samples drawn from restricted populations 
(eg, from a single organization or single sex); using 
cross-sectional designs; including only limited adjust-
ment for potential confounds; relying on self-reported 
indices of disease; and using quite vague or non-specific 
definitions of shift work. Thus there is a risk that such 
studies were statistically underpowered, lacking gen-
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eralizability, lacking the temporal element needed to 
established causality, subject to selection biases (eg, 
the “healthy shift worker effect”; 7) or subject to out-
come misclassification. Furthermore, the effects of shift 
work may have been diluted by a failure to distinguish 
between more and less harmful shift schedules (ie, those 
engendering more or less circadian disruption; 8).
An important element of ascertaining links between 
shift work and disease is the use of reliable indices 
of the presence of disease. In previous studies, objec-
tive assessments of health status were most commonly 
derived from physical examinations (eg, blood pres-
sure measurements or blood sampling, taken as part of 
a medical check-up; 2, 3). Collection of such data is 
labor intensive. Hence many of the studies of this type 
were based on relatively small samples or samples from 
restricted populations (eg, the employees of a single 
organization; 9, 10). Another less commonly used objec-
tive index of disease status is the administrative records 
of medication prescriptions / purchases. The use of 
medication is in most cases likely to correspond closely 
with the medical diagnosis of a disease. Moreover, 
where medication prescription / purchase records are 
available nationally (as in national register data that is 
collected in Scandinavian countries), it affords the pos-
sibility to examine associations within a broad sample 
of the population. We are aware of only one published 
study to date that used data from national registers of 
prescribed medication purchases to examine associa-
tions between shift work and any of the diseases that are 
the focus of the current study (11). This study found no 
association between shift work status and the purchase 
of hypertension medication, although the study suffered 
from using a broad definition of shift work.
To address the methodological issues outlined above, 
the current study sought to examine prospectively the 
potential associations between specific forms of shift 
work and objective indices of disease, in two large 
national surveys of male and female workers in a range 
of occupations, comparing shift workers with day work-
ers in the same range of occupations. The survey data 
were linked to national register data on the purchase of 
medications for the treatment of (i) hypertension or high 
blood pressure (ii); type 2 diabetes; and (iii) dyslipidemia 
(a commonly studied biomarker of atherosclerosis). The 
surveys included detailed questions on a broad range 
of background characteristics and work schedules, thus 
facilitating the separate study of rotating shift schedules 
that either did, or did not, involve nightwork. It also made 
it possible to account for a range of potential confounders 
that could distort findings, such as health behaviors and 
previous shift work history. In order to address the issue 
of selection effects, the analyses were stratified by age, as 
selection out of shift work due to the development of ill-
health is most likely to occur among older shift workers.
It was hypothesized that shift work would be associ-
ated with greater use of each type of medication, after 
adjusting for potential confounders relating to demo-
graphic and economic background, and health behav-
iors. It was further anticipated that these effects would 
be greater for shift work that included night work than 
for shift work that did not, due to the greater level of 
circadian disruption that is caused by night work.
Method
Participants
Data were obtained from three waves of the Finnish Pub-
lic Sector (FPS) study (2000, 2004, and 2008, response 
rates 66–68%). The FPS comprised two cohorts: the 
10-town cohort, a study of local government employees 
in ten towns (a mixture of healthcare workers – mainly 
in residential long-term care settings – and enemploy-
ees from other occupational sectors) and the Work and 
Health in Finnish Hospital Personnel Study, a study 
conducted within 21 hospitals, referred to here as the 
hospitals cohort. The total number of participants in 
the two cohorts before exclusions (see below) was 
N=59 199 and N=27 364, respectively.
Participants entered the study at different points 
(ie, either 2000, 2004, or 2008), depending on their 
work schedule status at the time they first responded to 
the survey. The follow-up for purchases of prescribed 
medication began from the start of the year following 
the survey. Respondents classified as day workers were 
excluded if their occupation did not match the occupa-
tion of at least one of the participants classified as shift 
workers (see below); this resulted in the exclusion of 
3.6% of the original sample of day workers. For each 
analysis, we excluded respondents who had purchased 
the medication in question during the 12 months preced-
ing follow-up and those who reported at baseline ever 
having been diagnosed by a doctor with either hyper-
tension, myocardial infarction, angina pectoris, stroke/
cerebrovascular disease or diabetes. For the analysis of 
each model, participants with incomplete baseline data 
for the relevant covariates were excluded.
Shift work status
For the purposes of the current analyses, participants 
were classified as either day workers, shift workers with-
out night shifts or shift workers with night shifts. Clas-
sification was based on their survey response at baseline.
In the 10-town cohort, participants in the 2000 and 
2004 waves were asked: "Is your work regular day 
work?", with the response options "Yes" or "No". If 
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answering in the negative, they were then asked to 
indicate if their work included (i) evening (ii), night, or 
(iii) weekend shifts. Participants were classified as day 
workers if they answered "Yes" to the initial question; 
as shift workers without night shifts if they answered 
"No" to the initial question and then indicated that their 
work included evening shifts but not night shifts; or as 
shift workers with night shifts if they answered "No" to 
the initial question and then indicated that their work 
included both evening shifts and night shifts. Partici-
pants selecting any other combination of responses were 
excluded from the analyses (N=1062).
In the Hospitals Cohort and the 2008 wave of the 
10-town cohort, participants were classified according 
to whether they chose to describe their current work as 
either day work, shift work without night shifts, or shift 
work with night shifts. These questionnaire items have 
previously been validated against an objective measure 
of shift work status based on payroll data (12). Partici-
pants who reported regular night work or other irregular 
work / other were excluded from the analyses (N=1786).
Use of prescription medicine
Data on the dates of purchases of prescription medi-
cation were retrieved from the Drug Reimbursement 
Register from 1 January 1999 to 31 December 2011. 
The analyses focused on specific medications related 
to three medical conditions, based on the anatomical 
therapeutic chemical (ATC) classification system. The 
three categories were: type-2 diabetes (A10B, A10X); 
hypertension (C02, C03, C07, C08, C09); and dyslipid-
emia (C10AA, ie, statins). The date of the first purchased 
prescription was used to determine the occurrence of the 
medical condition.
Covariates
Covariates measured at baseline included sex, occupa-
tional status [four categories: upper white-collar (Interna-
tional Standard Classification of Occupations - ISCO=1-
2), lower white-collar (ISCO=3-4), skilled blue-collar 
(ISCO=5), other blue-collar (ISCO=6-9), marital sta-
tus (four categories: unmarried, married or cohabiting, 
divorced, widower), alcohol consumption (continuous 
measure: pure alcohol g/week), current smoking status 
(two categories: no, yes), physical activity (continuous 
measure: metabolic equivalent (MET) hours/week) and 
body mass index (BMI, continuous measure: kg/m2)]. All 
baseline data were obtained from the survey responses.
Data analysis
Participants' survey responses were linked to data on 
redeemed prescriptions and death obtained from the 
national registers using personal identification numbers 
and the linkage was successful for all respondents.
Associations between shift work status and any inci-
dent use of studied prescription medicine were examined 
using Cox proportional hazard regression models. Given 
that the two cohorts featured different exposure assess-
ments (see above) and also that the two cohorts worked 
in different occupational settings (and thus may differ 
with respect to, for example, shift patterns, or the distri-
bution of work tasks between shift workers and non-shift 
workers), initially it was decided to analyze data from 
the two cohorts separately. The intention was to ascer-
tain whether the associations between shift work status 
and medication use differed between the two cohorts, 
and if they did not, the two datasets would be combined 
into a single set of analyses. The results indicated that 
there were rather large differences and so the decision 
was taken to keep the two datasets separate. For each 
cohort, two sets of analyses were conducted separately 
for each of the three types of medication, one comparing 
shift workers without night shifts with day workers and 
the other comparing shift workers with night shifts with 
day workers. In order to test the Cox proportional hazard 
assumptions, the time-independent interaction between 
shift work groups and the follow-up period were exam-
ined and found to be statistically non-significant (results 
not shown), confirming that the proportional hazards 
assumption was justified (13).
Follow-up for day workers began from the begin-
ning of the first year (1 January) after they responded 
to the survey. Follow-up of shift workers with / without 
night shifts began from the beginning of the first year 
after they indicated that they were doing shift work 
with / without night shifts. Follow up time was calcu-
lated to the first date of purchase of medication, death 
or end of the follow up (ie, 31 December 2011), which 
ever came first. Each analysis was stratified by age at 
baseline (≤39, 40–49, and ≥50 years). We calculated 
hazard ratios (HR) and their 95% confidence intervals 
(CI) without adjustments (model 0); with adjustments 
for sex, occupational status and marital status (model 
1); with adjustments in model 1 plus adjustments for 
alcohol consumption, smoking and physical activity 
(model 2); and with adjustments in models 1 and 2 
plus BMI (model 3). This multiple-model approach 
was adopted in view of the potential role of some of 
the covariates as mediators of the associations under 
study. Alcohol consumption, smoking, physical activ-
ity, and especially BMI are all potential mediators 
of the outcomes and therefore their inclusion risked 
masking associations through over-adjustment. In 
order to account for the non-Gaussian distributions of 
the variables measuring alcohol consumption, physical 
activity, and BMI, these variables were entered along 
with their squared terms.
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Sensitivity analyses were conducted to investigate 
the possibility that having former shift workers in the 
control groups could produce an under-estimation of 
the true impact of shift work. These analyses were only 
possible in the hospital cohort, where shift work history 
was reported. The sensitivity analyses involved repeat-
ing the main analyses (as described above), but with the 
modification that day workers were excluded from the 
control group if they reported having previously worked 
shifts for more than one year. The results were compared 
with those of the main analyses to see whether these 
supplementary analyses produced stronger effects than 
the main analyses. If they did, this would be taken as 
an indication that the main analyses underestimated the 
true impact of shift work, due to the 'contamination' of 
the control sample by former shift workers.
The statistical analyses were conducted with SAS 
9.4 (SAS Institute Inc, Cary, NC, USA).
Ethical approval
The ethics committee of the Hospital District of Helsinki 
and Uusimaa (HUS) approved the FPS study (HUS 
1210/2016).
Results
The mean follow-up times were 8.1 years for the analy-
ses of type 2 diabetes, 7.2 years for hypertension and 
7.8 years for dysplidemia. Table 1 shows the number 
of participants included for each of the three types of 
medication examined, as well as sex distributions and 
mean ages. As also shown in the table, the samples did 
not differ substantially from the full study sample with 
respect to sex distribution or mean age.
Descriptive statistics of the final samples for each 
cohort, broken down by work schedule, are presented in 
tables 2a and b. Age distributions were similar between 
day workers and shift workers without night shifts, but 
there were higher proportions of younger (≤39 years) 
shift workers with night shifts. Sex distributions were 
broadly similar across the three types of work schedule, 
with the majority of both day and shift workers being 
female. The distributions of occupational status differed 
between the three types of work schedule, with the 
majority of day workers being in the upper two strata, 
shift workers without night shifts being relatively evenly 
spread between the four strata, and the majority of shift 
workers with nights being in the middle two strata. The 
distributions of marital status did not differ between the 
three types of work schedule, with the majority in each 
cohort being married or cohabiting. Shift workers (both 
types) were somewhat more likely to be smokers but 
tended to consume less alcohol (with the exception of 
shift workers with nights in the 10-town cohort), while 
levels of physical activity and BMI were quite similar 
across the three types of work schedule.
Table 3 presents the observed cumulative incident 
proportions for the three medications, broken down by 
shift work status and age (a full breakdown of cumula-
tive incident proportions broken down by all predic-
tors and background variable categories is provided in 
supplementary table S1, www.sjweh.fi/show_abstract.
php?abstract_id=3813). For all three types of medica-
tion, any incident use tended to be highest among shift 
workers without night shifts and older individuals. 
Supplementary table S2 (www.sjweh.fi/show_abstract.
php?abstract_id=3813) presents the numbers of partici-
pants, events and person-years, stratified in accordance 
with main analyses.
Table 4 presents the results from the Cox regression 
analyses of associations between shift work status and any 
incident use of each of the three categories of medicine. 
(Note that the table only presents the results for models 1 
and 2; see Data analysis above. Results for models 0 and 
3 are presented in supplementary table S3, www.sjweh.fi/
show_abstract.php?abstract_id=3813). Results from the 
10-town cohort indicated several significant associations 
between work schedule and medication use, all of which 
were positive. There were also positive associations 
between shift work (both types) and any incident use of 
hypertension medication in both the lower and middle 
age ranges (≤39 and 40–49 years) after adjustment for 
sex, occupational status, marital status, alcohol consump-
tion, smoking, and physical activity (model 2). There 
were additional positive crude associations between shift 
work without night shifts and any incident use of diabetes 
medication in the middle age ranges after adjustments 
(models 1 and 2). Finally, there were positive associations 
between shift work with night shifts and any incident use 
of dyslipidemia medication in the middle age range after 
adjustments (models 1 and 2).
By contrast, in the hospital cohort, there were no 
significant positive associations between work sched-
ule and medication use, but there were some negative 
associations (ie, indicating shift workers were less likely 
Table 1. Baseline profiles: full study sample and samples included in 
analyses of each medication after exclusions. [SD=standard deviation.]
10-town cohort Hospital cohort
N  
(% female)
Baseline  
mean age (SD)
N  
(% female)
Mean age (SD)
Full study sample 42 846 (79.0) 43.8 (9.8) 24 046 (87.6) 42.5 (10.2)
Samples included 
after exclusions
Type-2 diabetes 38 209 (79.1) 43.0 (9.7) 21 762 (87.6) 42.3 (10.7)
Hypertension 34 583 (79.5) 42.2 (9.6) 19 892 (87.6) 41.5 (10.1)
Dyslipidemia 38 243 (79.2) 44.0 (9.7) 21 631 (87.6) 42.2 (10.1)
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Table 2a. Baseline descriptive statistics of final sample in each cohort, broken down by work schedule.
10-town cohort Hospital cohort
Day work Shift work without 
night shifts
Shift work with  
night shifts
Day work Shift work without 
night shifts
Shift work with  
night shifts
N % N % N % N % N % N %
Age at baseline
≤39 11 100 34 1994 31 1739 43 3519 31 1257 32 4523 52
40-49 10 744 33 2154 33 1275 32 3943 35 1139 29 2645 30
≥50 10 547 33 2307 36 986 25 3881 34 1510 39 1619 18
Sex
Male 6786 21 955 15 1269 32 1939 17 238 6 811 9
Female 25 605 79 5500 85 2731 68 9414 83 3668 94 7976 91
Occupational status
Upper white-collar 14 409 45 1147 18 212 5 3834 34 309 8 65 1
Lower white-collar 7065 22 1610 25 1115 29 5588 49 1533 39 6496 74
Skilled blue-collar 6263 19 2428 38 2359 59 728 6 522 13 2063 23
Other blue-collar 4654 14 1270 20 314 8 1203 11 1542 40 163 2
Marital status
Unmarried 3742 12 930 15 584 15 1148 10 511 13 1363 16
Married / cohabiting 24 482 77 4400 69 2850 72 8828 79 2788 72 6512 75
Divorced 3393 11 890 14 473 12 1114 10 491 13 767 9
Widow(er) 384 1 123 2 42 1 152 1 80 2 80 1
Smoking status
No 25 991 82 4793 77 2844 74 9394 88 2940 81 6885 84
Yes 5604 18 1463 23 1013 26 1221 12 711 19 1298 16
Table 2b. Baseline statistics of final sample in each cohort, broken down by work schedule. [BMI=body mass index; MET=metabolic equivalent 
SD=standard deviation; wk=week.]
10-town cohort Hospital cohort
Day work Shift work without 
night shifts
Shift work with  
night shifts
Day work Shift work without 
night shifts
Shift work with  
night shifts
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Alcohol consumption (g/wk) 68.0 103.8 59.1 97.2 75.2 130.9 56.8 88.9 47.1 98.2 46.4 80.3
Physical activity (MET hours/wk) 4.57 4.1 4.5 4.2 5.37 4.9 4.6 4.0 4.6 4.3 5.3 4.6
BMI (kq/m2) 25.1 4.3 25.5 4.5 25.9 4.4 24.8 4.6 25.2 4.1 24.6 4.0
Table 3. Sample size and frequency of any-incident use of medication, broken down by shift work status and age at baseline.
Medication
Type-2 diabetes Hypertension Dyslipidemia
N % new redemptions N % new redemptions N % new redemptions
10-town cohort
Shift work status
Day work 28 947 3.8 26 202 20.6 28 975 12.1
Shift work without night shifts 5653 4.6 5072 24.2 5658 13.3
Shift work with night shifts 3609 3.5 3309 21.2 3610 12.2
Age at baseline
≤39 14 056 1.6 13 784 12.8 14 150 3.1
40–49 12 868 3.8 11 726 23.7 12 942 12.3
≥50 11 285 6.9 9073 30.7 11 151 23.8
Hospital cohort
Shift work status
Day work 10 215 3.7 9225 25.4 10 139 12.9
Shift work without night shifts 3512 4.0 3121 26.7 3505 13.8
Shift work with night shifts 8035 2.8 7546 21.9 7987 8.4
Age at baseline
≤39 8564 1.9 8438 15.9 8598 2.4
40–49 7051 2.8 6497 28.5 7035 11.5
≥50 6147 6.2 4957 33.1 5998 24.0
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than day workers to use medication). Shift workers with 
night shifts who were in the middle age range showed 
a lower risk for purchasing hypertension medication 
after adjustment for sex, occupational status, and marital 
status (model 1), although the association disappeared 
after additional adjustment for alcohol consumption, 
smoking and physical activity (model 2). There were 
also negative associations between shift work with night 
shifts and any incident use of dyslipidemia medication 
in the middle age range medication after adjustments 
(models 1 and 2).
In the sensitivity analyses of the data from the hos-
pital cohort, we found that excluding day workers who 
reported having previously worked >12 months in shift 
work made very little difference to the pattern of results 
obtained (results not shown).
Discussion
The results of this large prospective cohort study with 
linked prescription data and a follow-up of 11 years 
provided mixed evidence of associations between shift 
work and incident use of medications for type-2 diabe-
tes, dyslipidemia, and hypertension. In the larger of the 
two cohorts, shift work was associated with greater use 
of medications for diabetes and dyslipidemia among the 
40–49-year-old employees but not among the younger 
or older workers. Shift work was also associated with 
greater use of antihypertensive medication among work-
ers <50 years. The smaller cohort, however, provided no 
evidence of positive associations between shift work and 
medication use.
The finding of associations between shift work and 
type-2 diabetes in the 10-town cohort is consistent with 
previous research, as reflected in the findings of two 
recent meta-analyses (5, 6). Unexpectedly, however, 
we found risk to be greater among shift workers without 
night shifts than among shift workers with night shifts. 
This was somewhat surprising given that the increased 
risk of diabetes among shift workers is thought to be 
linked to circadian disruption and sleep deprivation, 
which tend to be greater among those whose schedule 
includes night shifts. The finding may reflect selection 
out of night work into shift work without nights, as 
was observed in another recent study based on the FPS 
study (14). In that study, a lack of association between 
night work and common mental disorders (CMD) was 
found to be mainly attributable to the greater likelihood 
of night workers with CMD moving back to non-night 
work. (In most cases it is likely to be easier organize 
a transfer from shift work with nights to shift work 
without nights, rather than a transfer to day work.) Such 
selection processes are the likely effect of occupational 
health practice in Finland which is based on the EU 
working hours directive (2003/88/EC). This requires 
that night workers suffering from health problems such 
as diabetes should be transferred to non-night work 
whenever possible. Such practices may differ between 
settings and between countries (eg, between countries 
that are within the EU and those that are outside the 
EU). This may go some way to explaining the contrast-
ing findings between studies with regard to the relative 
risks associated with shift work that either does or does 
not include night work.
Previous research has produced mixed findings regard-
ing a possible risk of increased cholesterol levels among 
Table 4. Associations between shift work without night shifts and shift work with night shifts and any incident use of medication.
Model 10-town cohort, age at baseline Hospital  cohort, age at baseline
≤39 years 40–49 years ≥50 years ≤39 years 40–49 years ≥50 years
HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Hypertension
Shift work without  
night shifts
1 a 1.22 1.07–1.39 1.13 1.02–1.25 1.05 0.94–1.16 1.10 0.92–1.30 1.04 0.91–1.20 1.06 0.93–1.21
2 b 1.20 1.05–1.37 1.16 1.04–1.29 1.05 0.95–1.17 1.11 0.93–1.33 1.06 0.92–1.22 1.04 0.91–1.20
Shift work with  
night shifts
1 a 1.14 0.98–1.33 1.13 0.99–1.30 1.06 0.91–1.23 0.89 0.77–1.02 0.88 0.78–0.99 0.95 0.82–1.09
2 b 1.18 1.00–1.38 1.16 1.01–1.33 1.05 0.90–1.22 0.91 0.79–1.04 0.90 0.80–1.02 0.95 0.82–1.09
Type-2 diabetes
Shift work without  
night shifts
1 a 1.23 0.87–1.73 1.28 1.01–1.62 0.91 0.74–1.11 1.05 0.63–1.74 1.33 0.88–2.02 0.83 0.63–1.10
2 b 1.24 0.87–1.75 1.28 1.01–1.62 0.87 0.70–1.08 0.92 0.54–1.55 1.28 0.84–1.94 0.84 0.63–1.12
Shift work with  
night shifts
1 a 1.03 0.67–1.59 0.93 0.66–1.29 0.93 0.70–1.24 1.04 0.70–1.54 1.24 0.86–1.79 0.78 0.57–1.07
2 b 1.06 0.68–1.66 0.90 0.64–1.28 0.93 0.69–1.25 1.09 0.74–1.63 1.30 0.91–1.88 0.79 0.57–1.09
Dyslipidemia
Shift work without  
night shifts
1 a 1.23 0.95–1.59 1.02 0.89–1.18 1.04 0.93–1.16 1.19 0.78–1.81 1.21 0.98–1.48 1.02 0.88–1.18
2 b 1.19 0.91–1.56 1.03 0.90–1.19 1.04 0.94–1.17 1.12 0.73–1.73 1.21 0.98–1.50 1.03 0.89–1.20
Shift work with  
night shifts
1 a 1.09 0.81–1.47 1.26 1.07–1.49 1.01 0.86–1.18 0.94 0.64–1.38 1.03 0.86–1.23 0.81 0.69–0.94
2 b 1.17 0.87–1.59 1.33 1.12–1.57 1.00 0.85–1.17 0.94 0.63–1.37 1.07 0.89–1.28 0.81 0.69–0.95
a Adjusted for sex, occupational status, and marital status.
b Model 1 + alcohol consumption, (alcohol consumption)2, smoking, physical activity, and (physical activity)2. Results for Models 0 and 3 are presented in the online 
supplementary material (see text). Significant associations in bold.
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shift workers, although an earlier review concluded that 
there was little evidence of an association (3). The cur-
rent finding of greater use of medication for dyslipidemia 
(ie, mainly statins) by shift workers with night shifts in 
the middle age range might be seen as lending support 
to a link between shift work and dyslipidemia. However, 
interpretation of these particular results is complicated 
by the fact that statins are sometimes prescribed to CVD 
patients (or potential patients) in the absence of direct 
evidence of dyslipidemia (15). Thus, we cannot be sure 
whether the current finding demonstrates a link between 
shift work and dyslipidemia or between shift work and 
some other disease(s) for which statins may sometimes 
be prescribed (eg, multiple sclerosis, inflammatory bowel 
disease, rheumatoid arthritis).
Some of the crude associations between shift work 
and use of medications were weakened after controlling 
for individual differences and situational factors (sex, 
occupational status, and marital status; model 1. See 
supplementary table S3). Additional controlling for life-
style factors (alcohol consumption, smoking, physical 
activity (model 2) and for BMI (model 3) had little clear 
and systematic effect on the strengths of associations 
across the entire set of analyses. Nevertheless, there 
were some instances where the associations between 
work schedule and use of medications for diabetes and 
dyslipidemia became weaker after controlling for body 
mass index. Obesity is strong risk factor for type-2 
diabetes (16) and hyperlipidemia (17). Since shift work 
and sleep deprivation increase appetite, weight gain, 
and obesity over time (18), controlling for obesity in 
the current analyses probably lead to an underestimation 
of the associations between shift work and diabetes and 
between shift work and dyspidemia.
The finding of associations between shift work and 
use of hypertension medication is consistent with find-
ings from several other longitudinal studies that have 
suggested a link between shift work and hypertension 
symptomatology, based on measurements of blood 
pressure, self-reports of treatment for hypertension, or 
records of medical insurance claims (3, 9, 10, 19–20). 
In the current study, both forms of shift work (with and 
without nights) were associated with greater use of anti-
hypertensive medication. This contradicted our predic-
tion that risk of disease would be higher for shift work 
with nights due to greater circadian disruption. Given 
that both categories of shift worker in the current study 
worked evening shifts as part of their rotating schedule, 
our findings might suggest that it is exposure to evening 
shifts that leads to increased use of antihypertensive 
medication. Evening shifts are unlikely to be especially 
disruptive to circadian rhythms, but they may cause 
other problems that increase the risk of hypertension. 
For example, evening shifts can be especially disruptive 
to social and family life; moreover, the late finishing 
times of evening shifts may cause problems for unwind-
ing and falling asleep (21). Epidemiological studies 
suggest that hypertension is associated with short sleep 
(22–24). Another possibility is that some night workers 
suffering from high blood pressure have been transferred 
to non-night work whenever possible.
In contrast to the previous findings of associations 
between shift work and hypertension symptomatology 
(3, 9, 10, 19), the only previous study of links between 
shift work and hypertension medication purchase (based 
on objective register data) found no significant associa-
tion (11). Both that study and the current study were 
prospective cohort studies, based on large samples of 
the Finnish population, adjusting for a similar range of 
potential confounders. The authors of the earlier study 
conceded that their use of an imprecise definition of shift 
work might have attenuated any associations with the 
outcome variable. While the current study used rather 
more specific definitions of shift work, it is plausible that 
the discrepancy between the significant findings in the 
10-town cohort, and the non-significant findings in both 
the hospital cohort and the previous study by Hublin et 
al (11), may be due to unmeasured differences in the 
precise nature of the shift schedules (eg, the regularity 
of the shift patterns or the intensity of nightwork).
The current findings of associations between shift 
work status and use of antihypertensive medication 
should be interpreted cautiously as some of these drugs 
are used to treat common symptoms and conditions 
such as (premenstrual) oedema and migraine. Thus, they 
should be regarded as consistent with, rather demonstra-
tive of, a link between shift work and hypertension.
The majority of significant associations (after adjust-
ment for confounders) were observed in the middle age 
groups. It could be expected that medication would 
tend to be greater among middle-aged than younger 
workers, given that any negative effects of shift work 
on health will develop over a prolonged period. Thus, 
for example, Pan et al (25) reported a dose‒response 
relationship between shift work exposure and risk of 
developing type-2 diabetes, such that every five years 
exposure to rotating night shifts was associated with a 
5% increased risk. Dose‒response relationships have 
also been observed between shift work exposure and 
other related health complaints such as metabolic syn-
drome (26) and cardiovascular heart disease (27). Such 
an effect of accumulated shift work exposure would 
account for the greater number of significant associa-
tions among the middle-aged groups in the current study, 
as compared to the younger-aged groups.
Dose‒response relationships are, however, inconsis-
tent with the relatively low (and mostly non-significant) 
risks observed among the oldest age groups. And yet, it 
is not uncommon for associations between shift work 
and health to be less strong, or even absent, in the 
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groups with the greatest exposure due to strong selection 
effects that are often observed in shift work research. For 
example, in the classic study of the association between 
shift work and ischemic heart disease by Knutsson and 
colleagues (28), risk was increased among those with 
11–15 years of exposure and further increased among 
those with 16–20 years exposure, but then risk fell 
sharply after 20 years of shift work. This decrease in 
risk was attributed to selection effects (“the healthy shift 
worker effect”), whereby only the healthiest and most 
resilient individuals remain in shift work after such a 
long period of exposure (29). EU legislation requires 
regular health checks for shift workers and that work-
ers be transferred to day work when health problems 
are identified, a practice that is common in Finland. 
Thus, the lack of effects in the older age group in the 
current study may well reflect such selection processes. 
Another factor to consider is that old age is associated 
with the accumulation of competing risk factors, thereby 
diminishing the relative role of shift work compared to 
these other factors.
Shift work had largely neutral or even negative (ie, 
protective) effects in the hospital cohort, while positive 
(ie, harmful) effects were more prevalent in the 10-town 
cohort. The hospital cohort featured a substantially 
smaller sample and therefore had lower statistical power. 
This could account for the relative lack of positive 
effects but would not explain the presence of negative 
effects. The results of sensitivity analyses provide no 
evidence that the control sample in the hospital cohort 
was 'contaminated' by prior exposure to shift work, 
which could have produced a left truncation bias (30). 
This suggests that the effects of shift work were not 
underestimated in the hospital cohort due to the control 
sample including individuals whose health had been 
negatively affected by previous exposure to shift work 
(ie, bias in selection out of shift work; the 'healthy shift 
worker survival effect'). Another more likely explanation 
for the discrepant results, as noted above, is that the cur-
rent analyses do not take into account the precise nature 
of the shift schedules. It has been shown previously that 
introducing more ergonomic shift schedules can, for 
example, produce positive changes in cholesterol levels 
(31). It may be that at least some shift workers in the 
10-town cohort had more demanding schedules that, for 
example, promoted greater levels of circadian disrup-
tion, as compared to shift workers in the hospital cohort.
The strengths of the current study were that it exam-
ines three major health outcomes in a prospective cohort 
design based on two large employee cohorts with high 
participation rates linked to high quality national pre-
scription register data. Prospective designs are subject 
to less risk of error due to confounding or bias compared 
to retrospective designs (32). The use of register data 
removes subjectivity, and its associated potential inaccu-
racies and bias, from the assessment of the participants' 
state of health. The detailed survey data facilitated 
adjustment for a broad range of potential confounders. 
The measure of shift work status that was used in the 
hospital cohort and in the 2008 wave of the 10-town 
cohort has been validated against an objective measure 
based on payroll data (12). The risk of major selection 
bias was reduced by recruiting all cases and their con-
trols from the same cohort.
As noted above, interpretation of the study is limited 
by the lack of more detailed information regarding the 
shift patterns that were worked. Moreover, shift work-
ing status (past and present) was assessed through self-
reports, as were the majority of other measures included 
in the analyses. While self-reports of shift working 
status in this population have been shown to be reli-
able for day work and shift work with night shifts, they 
are less reliable for shift work without nights (8). This 
could have led to misclassification and an underestima-
tion of health effects associated with shift work without 
nights. Neither of the current analyses took into account 
possible changes in the participants' shift work status 
during follow up, which also increases the possibility 
of misclassification of work schedule.
The potential impact of selection bias out of shift 
work (ie, the 'healthy shift worker survival effect') was 
examined in the sensitivity analyses of the hospital 
cohort data. However, no information was available 
on the shift work history of participants in the 10-town 
cohort, thereby limiting the possibilities for determining 
whether those results could have been affected by day 
workers in the control group having previously worked 
shifts. Moreover, the possibility of selection bias into 
shift work (ie, the 'healthy shift worker hire effect') 
remains in both cohorts, as the control groups could 
have included individuals who had chosen to avoid ever 
entering shift work due to pre-existing medical condi-
tions or poor health. Such selection bias could lead to 
an underestimate of health effects.
The current study examined work schedule as a 
predictor of time to first incident use of medication, 
rather than the quantity of medication purchased or the 
duration of its use. Focusing on time to first incident 
use gives the most precise assessment of the association 
between the timing of exposure and the manifestation of 
the related medical condition. However, it also means 
that the analyses do not take into account the severity 
of the diagnosed condition or for how long treatment 
continued. More generally, there are methodological 
issues to consider around using medication purchase 
data as a proxy for medical diagnosis. There is no one-
to-one correspondence between the prescription of a 
medication and a particular indication. A particular type 
of medication may be prescribed for a range of pos-
sible indications (as noted above in relation to statins 
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and antihypertensive medications); and there may be a 
range of medications that are prescribed for a particular 
indication. Illnesses may go undiagnosed or may be 
misdiagnosed, such that the sufferer is not prescribed 
the appropriate treatment. For type-2 diabetes, dyslip-
idemia, and hypertension, the estimated prevalences 
of undiagnosed conditions are relatively high, ranging 
between 7‒38% (33, 34). Finally, there will have been 
a short interval between survey response (which took 
place in late autumn) and commencement of follow-up 
(the beginning of the next year) during which time the 
outcome (ie, recorded purchase of medication) could not 
occur – so called 'immortal time' (32). Such biases could 
not explain the observed differences in rates of medica-
tion use between the day and shift workers; however, 
they give us reason to be cautious when extrapolating 
from rates of medication use to prevalence of disease.
Finally, while the 10-town cohort comprised employ-
ees from a range of occupational sectors, the overall 
sample was nevertheless dominated by healthcare work-
ers and thus cannot be considered representative of all 
occupational sectors that employ shift workers.
In conclusion, the current findings provide mixed 
evidence regarding the use by shift workers of medica-
tions for type-2 diabetes, dyslipidemia, and hyperten-
sion, conditions that are well-known cardiovascular 
risk factors. It is possible that selection into and out of 
shift work may have affected the results, attenuating the 
observed associations. Future research on shift work and 
cardiovascular health should use more detailed informa-
tion on participants' current and previous working time 
arrangements, ideally in the form of objective working 
time records.
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